HIV / AIDS in the News

The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance - FinancialContent

 

‘Wanted to contribute': Fired USAID workers start new group to help HIV programs - NBC4 Washington

 

Remembering Mark Milano, a committed activist in the fight against HIV/AIDS - Gay City News

 

[Press release] IAVI announces first vaccinations in IAVI G004, a Phase 1 clinical trial of a promising HIV vaccine approach - European AIDS Treatment Group

 

Event-based PrEP dosing for women: a challenge to guidelines and an activist issue - European AIDS Treatment Group

 

Nearly all Ryan White HIV/AIDS Program patients virally suppressed in 2024 - Managed Healthcare Executive

 

Estimated Death Rates (per 100,000) of Adults and Adolescents with an HIV Diagnosis, by Sex - KFF

 

Free HIV, Hepatitis C testing for Ball State students available Jan. 8 - cardinalmediabsu.com

 

Free HIV, Hepatitis C testing for Ball State students available Jan. 8 - ballstatedailynews.com

 

Sunsetting UNAIDS is a Global and Domestic HIV Threat - POZ

 

Adults and Adolescents Living with an HIV Diagnosis, by Sex - KFF

 

Six Resolutions and Resources for Advocates in 2026 - avac.org

 

Perinatal HIV Prevention - Florida Department of Health in Miami-Dade County (.gov)

 

Community Programs - Florida Department of Health (.gov)

 

Test and Treat Program - Florida Department of Health in Lee County (.gov)

 

U=U (Undetectable=Untransmittable) - Florida Department of Health in Escambia County (.gov)

 

HIV/AIDS - Florida Department of Health in Miami-Dade County (.gov)

 

HIV/AIDS - Florida Department of Health in Escambia County (.gov)

 

HIV/AIDS - Florida Department of Health (.gov)

 

PrEP & PEP - Florida Department of Health (.gov)

 

HIV/AIDS - Florida Department of Health (.gov)

 

HIV/AIDS Surveillance - Florida Department of Health (.gov)

 

IAVI Announces First Vaccinations in a Phase I Trial of a Promising HIV Vaccine Approach - POZ

 

Predictions for 2026 from Alexa B. D’Angelo, Ph.D., M.P.H. and Jeremiah Johnson - Managed Healthcare Executive

 

Hepatosplenic Tuberculosis Mimicking Metastatic Malignancy and Immune Reconstitution Inflammatory Syndrome (IRIS) in an HIV-Positive Patient - Cureus

 

WHO releases updated recommendations on HIV clinical management - World Health Organization (WHO)

 

UBS raises Gilead Sciences stock price target to $145 on HIV drug outlook - Investing.com UK

 

Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication - Fierce Biotech

 

WHO releases updated recommendations on HIV clinical management - World Health Organization (WHO)

 

Patients With HIV Have Higher 30-Day Readmission Risk After Heart Failure, Acute MI - Infectious Disease Advisor